Saham membuat pergerakan terbesar sebelum pasar: Pfizer, Occidental Petroleum, Bank of America dan banyak lagi

Lihat perusahaan-perusahaan yang menjadi berita utama sebelum bel:

Grup Evergrande China — Chinese property giant Evergrande tumbled more than 10% on Hong Kong Stock Exchange, spooking Asian markets. The company has been scrambling to pay its suppliers, and warned investors twice in as many weeks that it could default on its debts. Last week Evergrande said its property sales will likely continue to drop significantly in September after declining for months.

Pfizer — The pharmaceutical giant kata Senin that trials showed its Covid vaccine was safe and effective when used in children ages 5 to 11. Pfizer and partner BioNTech said they would submit the results for approval “as soon as possible.” Shares of Pfizer were down about 1% in premarket trading.

Minyak Laredo, Minyak Bumi Barat — Saham minyak dan energi merosot dalam perdagangan premarket pada hari Senin. SPDR S&P Oil & Gas Exploration ETF turun lebih dari 3% di awal perdagangan, dengan laju untuk sesi negatif ke-3 berturut-turut. Laredo Petroleum turun lebih dari 8%, Callon Petroleum turun sekitar 6%, dan Occidental Petroleum turun hampir 5%. Kerugian datang karena minyak mentah jatuh di tengah kekhawatiran perlambatan ekonomi global terkait dengan pasar properti China.

Colgate-Palmolive — The consumer staples stock was upgrade to buy from hold by Deutsche Bank on Sunday. The investment firm said that Colgate’s difficulties with inflation and in some international markets was already priced in to its stock.

JPMorgan, Bank of America — Bank stocks slid in unison amid a decline in bond yields on slowdown fears. Investors flocked to Treasurys for safety as the stock market is set for its biggest sell-off in months. Big bank stocks took a hit as the falling rates may crimp profits. Bank of America and JPMorgan Chase were each down more than 2% in premarket trading. Citizens Financial Group dropped 3%, while Citigroup declined 2.5%.

AstraZeneca — The United Kingdom-based pharmaceutical company announced on Monday that its breast cancer drug Enhertu showed positive results in a phase-three trial. Shares of the company were up more than 1% in premarket trading.

ETF Inovasi ARK — Cathie Wood’s ARK Innovation ETF is down 2.75% in the premarket, on pace to snap a 3-day winning streak. Compugen, DraftKings, Coinbase and Square are so of the ETF’s biggest losers this morning.

— dengan pelaporan dari CNBC's Jesse Pound dan Yun Li.